Administration of DDD (2, 2-bis(parachlorophenyl)-1, 1-dichloroethane) to diabetics with hyaline vascular changes and hyperpolysaccharidemia; a preliminary report.
D001769:Blood; D003634:DDT / Q000031:analogs & derivatives; D048909:Diabetes Complications; D003920:Diabetes Mellitus; D003632:Dichlorodiphenyldichloroethane; D005025:Ethylene Dichlorides; D006818:Hyalin; D011134:Polysaccharides / Q000097:blood*
D005025:Ethylene Dichlorides; D011134:Polysaccharides; D003634:DDT; D003632:Dichlorodiphenyldichloroethane
BLOOD; DDT/derivatives; DIABETES MELLITUS/complications; POLYSACCHARIDES/in blood